Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002023557-24-000001
Filing Date
2024-05-28
Accepted
2024-05-28 16:25:17
Documents
1
Effectiveness Date
2024-05-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6498
  Complete submission text file 0002023557-24-000001.txt   7548
Mailing Address 65 GLEN RD. APT. H2 BROOKLINE MA 02445
Business Address 65 GLEN RD. APT. H2 BROOKLINE MA 02445 314-917-7620
Absco Therapeutics, Inc. (Filer) CIK: 0002023557 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-514428 | Film No.: 24992238